The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available G7 BiSpherical Acetabular Shell.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patient capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study.
* Patient aged of 18 years or more whose skeleton reached bone maturity.
* Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
* Rheumatoid arthritis.
* Correction of functional deformity.
* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
* Revision procedures where other treatment or devices have failed.
Inclusion criteria specific for patients receiving the G7 BiSpherical Shell with the G7 Freedom Constrained Liner:
* The Biomet G7 Freedom Constrained Liner is indicated for use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability, and for whom all other options to con-strained acetabular components have been considered.
Exclusion Criteria:
Absolute exclusion criteria include:
* Infection, sepsis, osteomyelitis.
Relative exclusion criteria include:
* Uncooperative patient or patient with neurologic disorders who is incapable of following directions.
* Osteoporosis.
* Metabolic disorders which may impair bone formation.
* Osteomalacia.
* Distant foci of infections which may spread to the implant site.
* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.
* Vascular insufficiency, muscular atrophy or neuromuscular disease.
* Patient unwilling or unable to give consent, or to comply with the follow-up program.
* Patient known to be pregnant or breastfeeding.
* Patient presenting any condition that would, in the judgment of the Investigator, place the patient at undue risk or interfere with the study.
* Patient institutionalized or known drug abuser or alcoholic or anyone who cannot understand what is required of them.
* Patient belonging to a vulnerable population.
Exclusion criteria specific for patients receiving the G7 BiSpherical Shell with the G7 Freedom Constrained Liner:
* Bone or musculature compromised by disease, infection, or prior implantation that cannot provide adequate support or fixation for the prosthesis.
Primary outcome measure(s)
Implant survivorship is assessed counting the number of implant revisions — 10 years
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.